XML 52 R39.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Investments in Other Entities (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Equity Method Investments | For the years ended December 31, 2024 and 2023, the Company’s equity method investment balance consisted of the following (in thousands):
|  | % of Ownership |  | December 31, 2023 |  |  | Initial Investment |  |  | Allocation of Net Income (Loss) |  |  | December 31, 2024 |
LaSalle Medical Associates – IPA Line of Business |  | 25% |  | $ | 9,866 |  |  | $ | — |  |  | $ | 3,262 |  |  | $ | 13,128 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,691 |  |  |  | — |  |  |  | (31 | ) |  |  | 1,660 |
CAIPA MSO, LLC |  | 30% |  |  | 13,660 |  |  |  | — |  |  |  | 952 |  |  |  | 14,612 |
I Health, Inc. |  | 25% |  |  | — |  |  |  | 5,968 |  |  |  | 109 |  |  |  | 6,077 |
Other * |  | 25% - 51% |  |  | 557 |  |  |  | 3,126 |  |  |  | 159 |  |  |  | 3,842 |
|  |  |  | $ | 25,774 |  |  | $ | 9,094 |  |  | $ | 4,451 |  |  | $ | 39,319 |
*Other consists of smaller equity method investments including those from the CHS acquisition.
|  | % of Ownership |  | December 31, 2022 |  |  | Initial Investment |  |  | Allocation of Net Income (Loss) |  |  | Funding |  |  | Adjustment of Fair Value** |  |  | Distribution |  |  | December 31, 2023 |
LaSalle Medical Associates – IPA Line of Business |  | 25% |  | $ | 5,684 |  |  | $ | — |  |  | $ | 4,182 |  |  | $ | — |  |  | $ | — |  |  | $ | — |  |  | $ | 9,866 |
Pacific Medical Imaging & Oncology Center, Inc. |  | 40% |  |  | 1,878 |  |  |  | — |  |  |  | (187 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,691 |
531 W. College, LLC ** |  | 50% |  |  | 17,281 |  |  |  | — |  |  |  | (508 | ) |  |  | 700 |  |  |  | 91 |  |  |  | (17,564 | ) |  |  | — |
One MSO, LLC ** |  | 50% |  |  | 2,718 |  |  |  | — |  |  |  | 938 |  |  |  | — |  |  |  | 3,260 |  |  |  | (6,916 | ) |  |  | — |
CAIPA MSO, LLC |  | 30% |  |  | 12,738 |  |  |  | — |  |  |  | 922 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 13,660 |
Other * |  | 25% |  |  | — |  |  |  | 325 |  |  |  | 232 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 557 |
|  |  |  | $ | 40,299 |  |  | $ | 325 |  |  | $ | 5,579 |  |  | $ | 700 |  |  | $ | 3,351 |  |  | $ | (24,480 | ) |  | $ | 25,774 |
* Other consists of smaller equity method investments. ** Investments deemed Excluded Assets that are solely for the benefit of APC and its common shareholders. These Excluded Assets were spun-off on December 26, 2023 as part of the Spin-off (see Note 20—“Segments”).

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration